Table 2.
Parameters | Treatments | |||
---|---|---|---|---|
Control | TAA | TAA + leaves extract | Leaves extract |
|
SOD (U/mg tissue) | 5.26 ± 0.67 | 3.47 ± 0.42ab | 4.23 ± 0.49ac | 5.34 ± 0.52 |
(−34.0) | (−19.6) | (+1.5) | ||
GSH (μmol/g tissue) | 8.69 ± 0.82 | 6.21 ± 0.55ab | 6.94 ± 0.62ac | 8.90 ± 0.68 |
(−28.5) | (−20.1) | (+2.4) | ||
Glycogen (mg/g tissue) | 9.34 ± 0.87 | 7.34 ± 1.19ab | 8.06 ± 0.81a | 9.03 ± 1.25 |
(−21.4) | (−13.7) | (−3.3) | ||
Total protein (mg/g tissue) | 247.43 ± 12.61 | 204.00 ± 8.43ab | 236.11 ± 17.58 | 254.29 ± 18.63 |
(−17.6%) | (−4.6%) | (+2.8%) | ||
Total lipid (mg/g tissue) | 143.00 ± 8.76 | 195.43 ± 14.97ab | 177.14 ± 8.09ac | 140.29 ± 10.26 |
(+36.7) | (+23.9) | (−1.9) |
aIndicates a significant difference between control and treated groups.
bIndicates a significant difference between the group treated with TAA and groups treated with TAA plus G. biloba leaves extract and G. biloba leaves extract.
cIndicates a significant difference between the group treated with TAA plus G. biloba leaves extract and group treated with G. biloba leaves extract.